VALANX Biotech

Austria

Greifenburg, Carinthia, Austria

http://valanx.bio

Company profile

VALANX Biotech company profile

VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.

Business identity

Website: http://valanx.bio
Operating status: Active
Company type: For Profit
Employee range: 00011-00050 employees
Revenue range: $1K+
Founded: 2017-03-23

LinkedIn Facebook X

Headquarters

Headquarters: Greifenburg, Carinthia, Austria
Postal code: 8020
Country code: AT
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Seed
Funding rounds: 7
Total equity funding: $2.6M
Last funding: Seed / 2024-07-16
Last equity funding: Seed
Investors: 6
Lead investors: 3
Founders: 2
Articles: 9

Categories and groups

Biotechnology Health Care Medical Pharmaceutical Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Michael LukeschPatrik Fladischer

Lead investors

SkyGeneSOSVXISTA Science Ventures

Investors

austria Wirtschaftsservice (aws)RebelBioSOSVtecnet equityXISTA Science Ventures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.